With big-name backing, a startup launches to match cancer patients with clinical trials
SAN FRANCISCO — An ambitious startup aimed at connecting cancer patients with clinical trials launched on Thursday, one that is betting a smartphone app can help close the notorious gap between patients seeking experimental treatments and cancer centers ready to offer it.
Driver, as the company is called, will charge cancer patients $3,000 upfront plus a $20 monthly fee — all out of pocket — for a service that analyzes their tumor sample and their medical record. Driver uses that information to recommend options for both approved treatments and clinical trials as well as facilitate referrals via an app that patients can access on their phones.
The startup is being launched with backing from Hong Kong’s richest man, Li Ka-shing, and with the support of other high-profile figures, including
You’re reading a preview, subscribe to read more.
Start your free 30 days